Can We Quantify Melanoma Risk Based on a Specific Gene Mutation?

Can We Quantify Melanoma Risk Based on a Specific Gene Mutation?

Recent data suggest a lower relative risk for melanoma associated with CDKN2A gene mutation. read article Dr. Wolfe is a contributor to Practical Dermatology, a monthly publication that provides coverage of medical care, cosmetic advancements and practice management for clinicians in the field.

By | 2018-11-22T06:21:35+00:00 November 2nd, 2007|Skin Cancer / Melanoma|0 Comments

Leave A Comment

CallEmail GalleryDirections
Call